I’d say within the next three months (if not sooner) seems likely to me.
Their cash position went from $69.8M to $34.7M in a single quarter. In early April they paid another $4.8M in state royalties. They still have $13.5M of historical royalties owing which they’re paying in monthly instalments up to November. On page 6 under ‘short term liquidity’ they make it clear they are “actively considering working capital financing options to improve cash management and provide balance sheet liquidity”. Considering the large amount of debt the company is already carrying, what else is there except another capital raise?
- Forums
- ASX - By Stock
- BCB
- Ann: Investor Presentation March 2024 Quarterly Update
Ann: Investor Presentation March 2024 Quarterly Update, page-32
-
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $23.44M |
Open | High | Low | Value | Volume |
0.8¢ | 1.0¢ | 0.8¢ | $386.9K | 46.76M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 22497013 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 5616299 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 22131013 | 0.008 |
35 | 50302637 | 0.007 |
37 | 16468544 | 0.006 |
19 | 19082440 | 0.005 |
5 | 3825000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 5356299 | 11 |
0.010 | 1258978 | 8 |
0.011 | 2301116 | 4 |
0.012 | 3621909 | 7 |
0.013 | 1678059 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
BCB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online